全球感染性物品包装研究报告

GlobalInfectiousSubstancePackagingMarketResearchReport2023

GlobalInfectiousSubstancePackagingMarketResearchReport2023

Summary

TheglobalInfectiousSubstancePackagingmarketwasvaluedatUS$xxmillionin2022andisanticipatedtoreachUS$xxmillionby2029,witnessingaCAGRofxx%duringtheforecastperiod2023-2029.TheinfluenceofCOVID-19andtheRussia-UkraineWarwereconsideredwhileestimatingmarketsizes.

NorthAmericanmarketforInfectiousSubstancePackagingisestimatedtoincreasefrom$xxmillionin2023toreach$xxmillionby2029,ataCAGRofxx%duringtheforecastperiodof2023through2029.

Asia-PacificmarketforInfectiousSubstancePackagingisestimatedtoincreasefrom$xxmillionin2023toreach$xxmillionby2029,ataCAGRofxx%duringtheforecastperiodof2023through2029.

ThemajorglobalmanufacturersofInfectiousSubstancePackagingincludeAirSeaContainers,CIBESMEDLtd,ALEXBREUERGMBH,E3Cortex,BerlinPackagingLLC,CFTCanada,ICC,Therapak™,andSerpac,etc.In2022,theworld'stopthreevendorsaccountedforapproximatelyxx%oftherevenue.

ReportScope

ThisreportaimstoprovideacomprehensivepresentationoftheglobalmarketforInfectiousSubstancePackaging,withbothquantitativeandqualitativeanalysis,tohelpreadersdevelopbusiness/growthstrategies,assessthemarketcompetitivesituation,analyzetheirpositioninthecurrentmarketplace,andmakeinformedbusinessdecisionsregardingInfectiousSubstancePackaging.

TheInfectiousSubstancePackagingmarketsize,estimations,andforecastsareprovidedintermsofsalesvolume(KUnits)andrevenue($millions),considering2021asthebaseyear,withhistoryandforecastdatafortheperiodfrom2017to2028.ThisreportsegmentstheglobalInfectiousSubstancePackagingmarketcomprehensively.Regionalmarketsizes,concerningproductsbyType,byApplication,andbyplayers,arealsoprovided.

Foramorein-depthunderstandingofthemarket,thereportprovidesprofilesofthecompetitivelandscape,keycompetitors,andtheirrespectivemarketranks.Thereportalsodiscussestechnologicaltrendsandnewproductdevelopments.

ThereportwillhelptheInfectiousSubstancePackagingmanufacturers,newentrants,andindustrychainrelatedcompaniesinthismarketwithinformationontherevenues,salesvolume,andaveragepricefortheoverallmarketandthesub-segmentsacrossthedifferentsegments,bycompany,byType,byApplication,andbyregions.

ByCompany

SegmentbyType

AirSeaContainers

CIBESMEDLtd

ALEXBREUERGMBH

E3Cortex

BerlinPackagingLLC

CFTCanada

ICC

Therapak™

Serpac

Friobox

UN2814

UN2900

UN3373

Others

SegmentbyApplication

HealthcareandMedicalLaboratories

PharmaceuticalIndustry

VeterinaryMedicine

HazardousWasteManagement

ConsumptionbyRegion

NorthAmerica

U.S.

Canada

Asia-Pacific

China

Japan

SouthKorea

ChinaTaiwan

SoutheastAsia

India

Australia

Europe

Germany

France

U.K.

Italy

Russia

RestofEurope

SouthAmerica

Mexico

Brazil

RestofSouthAmerica

CoreChapters

Chapter1:Introducesthereportscopeofthereport,executivesummaryofdifferentmarketsegments(byregion,producttype,application,etc),includingthemarketsizeofeachmarketsegment,futuredevelopmentpotential,andsoon.Itoffersahigh-levelviewofthecurrentstateofthemarketanditslikelyevolutionintheshorttomid-term,andlongterm.

Chapter2:DetailedanalysisofInfectiousSubstancePackagingmanufacturerscompetitivelandscape,price,salesandrevenuemarketshare,latestdevelopmentplan,merger,andacquisitioninformation,etc.

Chapter3:Sales,revenueofInfectiousSubstancePackaginginregionallevelandcountrylevel.Itprovidesaquantitativeanalysisofthemarketsizeanddevelopmentpotentialofeachregionanditsmaincountriesandintroducesthemarketdevelopment,futuredevelopmentprospects,marketspace,andmarketsizeofeachcountryintheworld.

Chapter4:ProvidestheanalysisofvariousmarketsegmentsbyType,coveringthemarketsizeanddevelopmentpotentialofeachmarketsegment,tohelpreadersfindtheblueoceanmarketindifferentmarketsegments.

Chapter5:ProvidestheanalysisofvariousmarketsegmentsbyApplication,coveringthemarketsizeanddevelopmentpotentialofeachmarketsegment,tohelpreadersfindtheblueoceanmarketindifferentdownstreammarkets.

Chapter6:Providesprofilesofkeyplayers,introducingthebasicsituationofthemaincompaniesinthemarketindetail,includingproductsales,revenue,price,grossmargin,productintroduction,recentdevelopment,etc.

Chapter7:Analysisofindustrialchain,includingtheupstreamanddownstreamoftheindustry.

Chapter8:Introducesthemarketdynamics,latestdevelopmentsofthemarket,thedrivingfactorsandrestrictivefactorsofthemarket,thechallengesandrisksfacedbymanufacturersintheindustry,andtheanalysisofrelevantpoliciesintheindustry.

Chapter9:Themainpointsandconclusionsofthereport.

TableofContents

1InfectiousSubstancePackagingMarketOverview

InfectiousSubstancePackagingMarketOverview

ProductDefinition

Infectioussubstancepackagingreferstothespecializedpackagingdesignedtosafelytransportandcontainmaterialsthatareknownorsuspectedtocontaininfectiousagents.Thesepackagingsystemsarespecificallydesignedtopreventthespreadofpathogensandprotectindividualsfrompotentialexposuretoharmfulmicroorganismsduringtransportation.

ProductPictureofInfectiousSubstancePackaging

Source:SecondarySourcesandQYResearch,2023

InfectiousSubstancePackagingbyType

byType,theInfectiousSubstancePackagingcanbesplitintoUN2814,UN2900,UN3373,Others,etc.

ThetablebelowvisuallyandclearlydetailsthemarketsizeofInfectiousSubstancePackaging,involume(KUnits)andvalue(US$Million),marketshareandgrowthtrendofeachtypein2023and2029.

TheCAGR(2023-2029)isbasedonthevalueofInfectiousSubstancePackagingforeachtypeandtheoverallmarket.

GlobalInfectiousSubstancePackagingMarketValueComparisonbyType(2023-2029)

GlobalInfectiousSubstancePackagingMarketValueComparisonbyType(2023-2029)&(US$Million)

byType

2018

2022

2029

CAGR(2018-2022)

CAGR(2023-2029)

UN2814

XX

XX

XX

XX%

XX%

UN2900

XX

XX

XX

XX%

XX%

UN3373

XX

XX

XX

XX%

XX%

Others

XX

XX

XX

XX%

XX%

Total

XX

XX

XX

XX%

XX%

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketValueComparisonbyType(2023-2029)&(US$Million)

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketSharebyType:2022&2029

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

UN2814

UN2814ProductPicture

Source:SecondarySourcesandQYResearch,2023

UN2900

UN2900ProductPicture

Source:SecondarySourcesandQYResearch,2023

UN3373

UN3373ProductPicture

Source:SecondarySourcesandQYResearch,2023

Others

OthersProductPicture

Source:SecondarySourcesandQYResearch,2023

InfectiousSubstancePackagingbyApplication

byApplication,theInfectiousSubstancePackagingmarketissub-segmentedintoHealthcareandMedicalLaboratories,PharmaceuticalIndustry,HazardousWasteManagement,etc.

Thissectiondisplaystheforecastofthemarketsizefrom2023to2029.TheCAGR(2023-2029)isbasedonthevolumeofInfectiousSubstancePackagingforbyApplicationandtheoverallmarket.

GlobalInfectiousSubstancePackagingMarketValuebyApplication(2023-2029)

GlobalInfectiousSubstancePackagingMarketValuebyApplication(2023-2029)&(US$Million)

byApplication

2018

2022

2029

CAGR(2018-2022)

CAGR(2023-2029)

HealthcareandMedicalLaboratories

XX

XX

XX

XX%

XX%

PharmaceuticalIndustry

XX

XX

XX

XX%

XX%

VeterinaryMedicine

XX

XX

XX

XX%

XX%

HazardousWasteManagement

XX

XX

XX

XX%

XX%

Total

XX

XX

XX

XX%

XX%

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketValuebyApplication(2023-2029)&(US$Million)

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

ThefollowingpiechartshowsthemarketshareofInfectiousSubstancePackagingbyApplicationinrevenuein2023and2029.

InInfectiousSubstancePackagingmarket,theHealthcareandMedicalLaboratoriesholdsanimportantshareintermsofapplication,anditisexpectedtoreachUS$xxmillionby2029,ataCAGRofxx%during2023and2029.

GlobalInfectiousSubstancePackagingMarketSharebyApplication:2022&2029

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

HealthcareandMedicalLaboratories

HealthcareandMedicalLaboratories

Source:SecondarySourcesandQYResearch,2023

PharmaceuticalIndustry

PharmaceuticalIndustry

Source:SecondarySourcesandQYResearch,2023

VeterinaryMedicine

VeterinaryMedicine

Source:SecondarySourcesandQYResearch,2023

HazardousWasteManagement

HazardousWasteManagement

Source:SecondarySourcesandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketSizeEstimatesandForecasts

GlobalInfectiousSubstancePackagingRevenue2018-2029

In2022,theglobalInfectiousSubstancePackagingmarketsizewasUS$XXmillionanditwillreachUS$XXmillionin2029,growingatCAGRofXX%between2023and2029.

Thedatafor2023isanestimate,basedonthehistoricaldataandtheintegratedviewofindustrialexperts,manufacturers,distributors,andendusers,etc.

Top-downandbottom-upapproachesareusedtovalidatetheglobalInfectiousSubstancePackagingmarketsizeandtoestimatethemarketsizeforcompany,regionaldivision,producttypeandapplication(endusers).Inthecompletemarketengineeringprocess,bothtop-downandbottom-upapproachesalongwithseveraldatatriangulationmethodshavebeenextensivelyutilizedtoperformmarketestimationandmarketforecastfortheoverallmarketdivisionandsubdivisionlistedinthisreport.Extensivequalitativeandfurtherquantitativeanalysishasalsobeendonefromallthenumbersarrivedatinthecompletemarketengineeringprocesstolistkeyinformationthroughoutthereport.

GlobalInfectiousSubstancePackagingRevenue,(US$Million),2018VS2022VS2029

CAGR:2018-2022

XX%

2018

2023

2029

CAGR:2023-2029

XX%

GrowthRate:2023

XX%

$XXMn

$XXMn

$XXMn

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketSize(2018-2029)&(US$Million)

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingSales2018-2029

In2022theglobalInfectiousSubstancePackagingsaleswerexxanditwillbexxin2029,withaCAGRofxx%between2023and2029.

GlobalInfectiousSubstancePackagingSales(2018-2029)&(KUnits)

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketAveragePrice(2018-2029)

GlobalInfectiousSubstancePackagingAveragePrice(US$/Unit)&(2018-2029)

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

AssumptionsandLimitations

Thisreportprovidesthe2018-2029marketdata(sales,revenue,andprice)reviewandforecastbyType,byApplication,andbyregion&country.

Thereportconsiders2022asthebaseyear.Allcalculationsinvolvingquantitativedataarebasedon2022.Thevalues&volumesrepresentedinthereportareactualvaluesfor2022,whereastherevenue&salesareestimatedfortheperiod2023–2029.Atinstanceswherethemarketsizefor2022wasnotavailablefromprimaryorsecondarysources,therevenue&saleswereestimatedbasedontheDelphimethod.

Marketsizehasbeenestimatedbasedonmanufacturers’InfectiousSubstancePackagingrevenue,salesquantity,andaveragesellingprices(APS).TherevenueisdeterminedbymultiplyingthenumberofInfectiousSubstancePackagingbytheaveragesellingprice(ASP)inUSdollars.Theaveragesellingpricesarenotretailprices;thepricesarebasedonthepriceoftheproductattheinitialfactorylevel.Thesearetheoriginalmanufacturer’s(“factory”)pricesinvoicedtothefirst(original)customer,ortransferpricesforinternal(captive)production.

Priceisdeterminedbytheforcechangeofsupplyanddemand.InfectiousSubstancePackagingpricetrendinthepastfiveyearsisasbelow.Andthefuturepricewillbeinfluencedbylotsoffactors.Ingeneral,pricingfluctuatesaccordingtogeneralprinciplesofsupplyanddemand,coststructuresandcurrencyexchange.Therearepriceadjustmentswhenconsideringhigh-endversuscommodityproducts.Ingeneral,higherperformanceproductsarepricedhigherandachievehighermargins.Thus,therehasbeengreaterfluctuationonthehigherendwherethereisgreaterroomtoadjustmargins.

Theregionaldistributionofthemarketrevenue,andsalesquantityhasbeenestimatedatthesameasthemanufactures’revenueandsalesquantitydistribution.TherealfigureshavebeenutilizedforCAGRestimation.TheCAGRhasbeencalculatedfortheforecastperiod2023-2029.Themarkethasbeenmappedbasedonvarioustypesofproductsavailableinthemarketandapplications(enduses).AllthekeymanufacturerswithconsiderablenumberofofferingsfortheInfectiousSubstancePackagingmarkethavebeenconsideredandprofiledinthereport.

PrimarysourcesverificationhasbeenconsideredtofinalizetheestimatedmarketfortheglobalInfectiousSubstancePackagingmarket.

SecondarysourceslikethelatestannualreportsofeachmarketplayerhavebeentakenintoconsiderationfortheglobalInfectiousSubstancePackagingmarketrevenuecalculation.

Marketstrategies,plansanddevelopmentsofkeyplayershavebeenconsideredforthecalculationofthesub-segmentsplit.

InfectiousSubstancePackagingReportYearsConsidered

Source:SecondarySources,ExpertInterviewsandQYResearch,2023

Note:Inthisstudy,2022hasbeenconsideredasthebaseyear;and2023to2029isastheforecastperiodtoestimatethemarketsizeforInfectiousSubstancePackaging.

Thebaseyearusedforcompanyprofilesis2022;whereinformationwasnotavailableforthebaseyear,thepreviousyearwasconsidered.

InfectiousSubstancePackagingMarketCompetitionbyManufacturers

GlobalInfectiousSubstancePackagingSalesMarketSharebyManufacturers(2018-2023)

ThekeyplayersintheglobalInfectiousSubstancePackagingmarketarelikeAirSeaContainersandCIBESMEDLtd,etc.Thesevendorshaveemployedvariousstrategiestoexpandtheirproductandapplicationofferings,globalfootprint,andaugmenttheirmarketshare.

Themarketisfragmentedduetothepresenceofmanylargeandsmallvendors.Thereportdiscussesthekeyvendorsinthemarketanddoesnotincludethemarketshareofallthevendorsinthemarket.

ThisreportfocusesonthemajormanufacturersofInfectiousSubstancePackagingaroundtheworld.ThefollowingtableshowstheInfectiousSubstancePackagingsalesandrevenueofthesecompanies,in2022.

GlobalInfectiousSubstancePackagingMarketCompetitiveSituationbyManufacturersin2022

Company

Sales(KUnits)

Revenue(US$Million)

Volume

MarketShare

Value

MarketShare

AirSeaContainers

XX

XX%

XX

XX%

CIBESMEDLtd

XX

XX%

XX

XX%

ALEXBREUERGMBH

XX

XX%

XX

XX%

E3Cortex

XX

XX%

XX

XX%

BerlinPackagingLLC

XX

XX%

XX

XX%

CFTCanada

XX

XX%

XX

XX%

ICC

XX

XX%

XX

XX%

Therapak™

XX

XX%

XX

XX%

Serpac

XX

XX%

XX

XX%

Friobox

XX

XX%

XX

XX%

Others

XX

XX%

XX

XX%

Total

XX

100%

XX

100%

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

ThetablebelowdetailstheInfectiousSubstancePackagingsalesandmarketshareofmajormanufacturers,from2018to2023.Thedatafor2023isanestimate,basedonthehistoricalfiguresandthedataweinterviewedthisyear.

Majormanufacturersinthemarketareidentifiedthroughsecondaryresearchandtheirmarketrevenuesdeterminedthroughprimaryandsecondaryresearch.Secondaryresearchincludedtheresearchoftheannualandfinancialreportsofthetopcompanies,whereas,primaryresearchincludedextensiveinterviewsofkeyopinionleadersandindustryexpertssuchasexperiencedfront-linestaff,directors,CEOsandmarketingexecutives.Thepercentagesplits,marketshare,growthrateandbreakdownsoftheproductmarketsaredeterminedthroughusingsecondarysourcesandverifiedthroughtheprimarysources.

GlobalInfectiousSubstancePackagingSales(KUnits)ofKeyManufacturers(2018-2023)

Company

2018

2019

2020

2021

2022

2023

AirSeaContainers

XX

XX

XX

XX

XX

XX

CIBESMEDLtd

XX

XX

XX

XX

XX

XX

ALEXBREUERGMBH

XX

XX

XX

XX

XX

XX

E3Cortex

XX

XX

XX

XX

XX

XX

BerlinPackagingLLC

XX

XX

XX

XX

XX

XX

CFTCanada

XX

XX

XX

XX

XX

XX

ICC

XX

XX

XX

XX

XX

XX

Therapak™

XX

XX

XX

XX

XX

XX

Serpac

XX

XX

XX

XX

XX

XX

Friobox

XX

XX

XX

XX

XX

XX

Others

XX

XX

XX

XX

XX

XX

Total

XX

XX

XX

XX

XX

XX

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingSalesMarketSharebyManufacturers(2018-2023)

Company

2018

2019

2020

2021

2022

2023

AirSeaContainers

XX%

XX%

XX%

XX%

XX%

XX%

CIBESMEDLtd

XX%

XX%

XX%

XX%

XX%

XX%

ALEXBREUERGMBH

XX%

XX%

XX%

XX%

XX%

XX%

E3Cortex

XX%

XX%

XX%

XX%

XX%

XX%

BerlinPackagingLLC

XX%

XX%

XX%

XX%

XX%

XX%

CFTCanada

XX%

XX%

XX%

XX%

XX%

XX%

ICC

XX%

XX%

XX%

XX%

XX%

XX%

Therapak™

XX%

XX%

XX%

XX%

XX%

XX%

Serpac

XX%

XX%

XX%

XX%

XX%

XX%

Friobox

XX%

XX%

XX%

XX%

XX%

XX%

Others

XX%

XX%

XX%

XX%

XX%

XX%

Total

XX%

XX%

XX%

XX%

XX%

XX%

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

InfectiousSubstancePackagingSalesSharebyManufacturersin2022

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingRevenueMarketSharebyManufacturers(2018-2023)

Themarketestimationsinthisreportarebasedontheex-factorypriceofInfectiousSubstancePackaging(excludinganydiscountsprovidedbythemanufacturers,distributors,wholesalers,ortraders).

ThetablebelowdetailstheInfectiousSubstancePackagingrevenueandmarketshareofmajormanufacturers,from2018to2023.

Thedatafor2023isanestimate,basedonthehistoricalfiguresandthedataweinterviewedthisyear.

GlobalInfectiousSubstancePackagingRevenue(US$Million)byManufacturers(2018-2023)

Company

2018

2019

2020

2021

2022

2023

AirSeaContainers

XX%

XX%

XX%

XX%

XX%

XX%

CIBESMEDLtd

XX%

XX%

XX%

XX%

XX%

XX%

ALEXBREUERGMBH

XX%

XX%

XX%

XX%

XX%

XX%

E3Cortex

XX%

XX%

XX%

XX%

XX%

XX%

BerlinPackagingLLC

XX%

XX%

XX%

XX%

XX%

XX%

CFTCanada

XX%

XX%

XX%

XX%

XX%

XX%

ICC

XX%

XX%

XX%

XX%

XX%

XX%

Therapak™

XX%

XX%

XX%

XX%

XX%

XX%

Serpac

XX%

XX%

XX%

XX%

XX%

XX%

Friobox

XX%

XX%

XX%

XX%

XX%

XX%

Others

XX%

XX%

XX%

XX%

XX%

XX%

Total

XX%

XX%

XX%

XX%

XX%

XX%

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingRevenueSharebyManufacturers(2018-2023)

Company

2018

2019

2020

2021

2022

2023

AirSeaContainers

XX%

XX%

XX%

XX%

XX%

XX%

CIBESMEDLtd

XX%

XX%

XX%

XX%

XX%

XX%

ALEXBREUERGMBH

XX%

XX%

XX%

XX%

XX%

XX%

E3Cortex

XX%

XX%

XX%

XX%

XX%

XX%

BerlinPackagingLLC

XX%

XX%

XX%

XX%

XX%

XX%

CFTCanada

XX%

XX%

XX%

XX%

XX%

XX%

ICC

XX%

XX%

XX%

XX%

XX%

XX%

Therapak™

XX%

XX%

XX%

XX%

XX%

XX%

Serpac

XX%

XX%

XX%

XX%

XX%

XX%

Friobox

XX%

XX%

XX%

XX%

XX%

XX%

Others

XX%

XX%

XX%

XX%

XX%

XX%

Total

XX%

XX%

XX%

XX%

XX%

XX%

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingRevenueSharebyManufacturersin2022

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingAveragePricebyManufacturers(2018-2023)

Thetablebelowshowstheaverageex-factorypriceofInfectiousSubstancePackagingforeachcompany,basedontherevenueandsalesofInfectiousSubstancePackaging.

GlobalMarketInfectiousSubstancePackagingAveragePrice(US$/Unit)ofKeyManufacturers(2018-2023)

Company

2018

2019

2020

2021

2022

2023

AirSeaContainers

XX

XX

XX

XX

XX

XX

CIBESMEDLtd

XX

XX

XX

XX

XX

XX

ALEXBREUERGMBH

XX

XX

XX

XX

XX

XX

E3Cortex

XX

XX

XX

XX

XX

XX

BerlinPackagingLLC

XX

XX

XX

XX

XX

XX

CFTCanada

XX

XX

XX

XX

XX

XX

ICC

XX

XX

XX

XX

XX

XX

Therapak™

XX

XX

XX

XX

XX

XX

Serpac

XX

XX

XX

XX

XX

XX

Friobox

XX

XX

XX

XX

XX

XX

Source:Abovecompanies;SecondarySourcesandQYResearch,2023

GlobalKeyPlayersofInfectiousSubstancePackaging,IndustryRanking,2021VS2022VS2023

GlobalKeyPlayersofInfectiousSubstancePackaging,IndustryRanking,2021VS2022VS2023

2021Rank

2022Rank

Company

Revenue:2021

Revenue:2022

1

1

AirSeaContainers

2

2

CIBESMEDLtd

3

3

ALEXBREUERGMBH

6

4

E3Cortex

4

5

BerlinPackagingLLC

5

6

CFTCanada

8

7

ICC

7

8

Therapak™

11

9

Serpac

9

10

Friobox

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalKeyManufacturersofInfectiousSubstancePackaging,ManufacturingSites&Headquarters

ThetablebelowpresentstheInfectiousSubstancePackagingmanufacturingbaseofmajormanufacturers.

GlobalKeyManufacturersofInfectiousSubstancePackaging,ManufacturingSites&Headquarters

Company

ManufacturingSites

Headquarters

AirSeaContainers

XX

XX

CIBESMEDLtd

XX

XX

ALEXBREUERGMBH

XX

XX

E3Cortex

XX

XX

BerlinPackagingLLC

XX

XX

CFTCanada

XX

XX

ICC

XX

XX

Therapak™

XX

XX

Serpac

XX

XX

Friobox

XX

XX

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalKeyManufacturersofInfectiousSubstancePackaging,ProductType&Application

ThetablebelowdetailstheInfectiousSubstancePackagingproducttypeandapplicationofmajormanufacturers.

GlobalKeyManufacturersofInfectiousSubstancePackaging,ProductType&Application

Company

ProductType

Application

AirSeaContainers

XX

CIBESMEDLtd

XX

ALEXBREUERGMBH

XX

E3Cortex

XX

BerlinPackagingLLC

XX

CFTCanada

XX

ICC

XX

Therapak™

XX

Serpac

XX

Friobox

XX

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalKeyManufacturersofInfectiousSubstancePackaging,DateofEnterintoThisIndustry

ThetablebelowpresentsthedatetoentertheInfectiousSubstancePackagingmarket.

GlobalKeyManufacturersofInfectiousSubstancePackaging,DateofEnterintoThisIndustry

Company

Year

AirSeaContainers

XX

CIBESMEDLtd

XX

ALEXBREUERGMBH

XX

E3Cortex

XX

BerlinPackagingLLC

XX

CFTCanada

XX

ICC

XX

Therapak™

XX

Serpac

XX

Friobox

XX

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketCompetitiveSituationandTrends

GlobalInfectiousSubstancePackagingMarketConcentrationRate

ThestandardtoolsofcompetitioneconomistsandcompetitionauthoritiestomeasuremarketconcentrationaretheHerfindahl-HirschmanIndex(HHI)andtheconcentrationratios(CR(n)).

TheHerfindahl-HirschmanIndex(HHI)isacommonmeasureofmarketconcentrationthatisusedtodeterminemarketcompetitiveness.TheHerfindahl-HirschmanIndex(HHI)isacommonlyacceptedmeasureofmarketconcentration.Itiscalculatedbysquaringthemarketshareofeachfirmcompetinginamarketandthensummingtheresultingnumbers.Itcanrangefromclosetozeroto10,000.

Theconcentrationratioisthepercentageofmarketshareownedbythelargestnfirmsinanindustry,wherenisaspecifiednumberoffirms.Inthisreport,wepresenttheCR5,meansthemarketshareofthefivelargestfirms.

Belowtabledetailsthemarketconcentrationratiointhepastthreeyears.Thetopfivemanufacturersheldxx%ofthemarket,intermsofInfectiousSubstancePackagingrevenuein2022.

GlobalManufacturersMarketConcentrationRatio(CR5andHHI)

Company

2021

2022

2023

AirSeaContainers

xx%

xx%

xx%

CIBESMEDLtd

xx%

xx%

xx%

ALEXBREUERGMBH

xx%

xx%

xx%

E3Cortex

xx%

xx%

xx%

BerlinPackagingLLC

xx%

xx%

xx%

CR5

xx%

xx%

xx%

HHI

xx

xx

xx

Source:Abovecompanies;SecondarySourcesandQYResearch,2023

TheGlobal5and10LargestInfectiousSubstancePackagingPlayersMarketSharebyRevenue

Global5and10LargestInfectiousSubstancePackagingPlayers:MarketSharebyRevenueinInfectiousSubstancePackagingin2022

Source:Abovecompanies;SecondarySourcesandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketSharebyCompanyType(Tier1,Tier2,andTier3)

Atpresent,theInfectiousSubstancePackagingplayershaveformedacompetitionformbetweenthefirsttierandthesecondtierandthethirdtier.

Note:the3tiersofcompaniesaredefinedbasedontheirrevenueinInfectiousSubstancePackagingasof2022.Tier1=>US$xxmillion,Tier2=US$xxmilliontoUS$xxmillion,andTier3=<US$xxmillion.

GlobalInfectiousSubstancePackagingbyCompanyType(Tier1,Tier2,andTier3)&(basedontheRevenueinInfectiousSubstancePackagingasof2022)

Company

Revenue(US$Million)in2022

CompanyType

AirSeaContainers

XX

Tier1

CIBESMEDLtd

XX

Tier1

ALEXBREUERGMBH

XX

Tier2

E3Cortex

XX

Tier2

BerlinPackagingLLC

XX

Tier3

CFTCanada

XX

Tier3

ICC

XX

Tier1

Therapak™

XX

Tier1

Serpac

XX

Tier2

Friobox

XX

Tier2

Others

XX

Total

XX

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

InfectiousSubstancePackagingMarketSharebyCompanyType(Tier1,Tier2,andTier3):2018VS2022

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

ManufacturersMergers&Acquisitions,ExpansionPlans

ManufacturersMergers&Acquisitions,ExpansionPlans

Date

BusinessActivity

Details

Source:Abovecompanies;SecondarySources,ExpertInterviewsandQYResearch,2023

GlobalInfectiousSubstancePackagingMarketScenariobyRegion

Themarketdata(salesandrevenue)ofInfectiousSubstancePackagingforeachregion,isdeterminedbythefinalapplication(“end-use”)andownershipofthatproduct.Forexample,oneunitInfectiousSubstancePackagingisproducedinU.S.andisthenshippedtotheEuropeandthenusedinEurope,thisreportwillbeshownasaInfectiousSubstancePackagingconsumed(used)intheEurope(notU.S.).

Note:inthisreport,salesandrevenuehavebeenestimatedbasedoncompanies’InfectiousSubstancePackagingsalesandrevenueineachregionandcountry.

TheNorthAmericasalesisthesumofallthecompanies’InfectiousSubstancePackagingsalesinNorthAmericamarket,includingtheNorthAmerica-Basedandforeigncompanies’InfectiousSubstancePackagingsales